Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis

Schisandrol A possesses pharmacological properties and is used to treat various diseases; however, its effects on osteoarthritis (OA) progression remain unclear. Here, we investigated Schisandrol A as a potential therapeutic agent for OA. In vitro, Schisandrol A effects were confirmed based on the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seong Jae, Jun, Jimoon, Eyun, Seong-il, Lee, Choong-Gu, Jeon, Jimin, Pan, Cheol-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999623/
https://www.ncbi.nlm.nih.gov/pubmed/33800441
http://dx.doi.org/10.3390/ph14030241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999623/
https://www.ncbi.nlm.nih.gov/pubmed/33800441
http://dx.doi.org/10.3390/ph14030241

Ejemplares similares